HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suhrid Banskota Selected Research

BJ-1301

10/2017Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suhrid Banskota Research Topics

Disease

10Colitis
11/2021 - 10/2016
9Neoplasms (Cancer)
01/2021 - 01/2015
8Inflammation (Inflammations)
01/2022 - 10/2016
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2020 - 10/2016
4Colonic Neoplasms (Colon Cancer)
10/2018 - 01/2015
3Lung Neoplasms (Lung Cancer)
10/2018 - 01/2015
3Body Weight (Weight, Body)
08/2018 - 10/2016
3Breast Neoplasms (Breast Cancer)
01/2018 - 01/2016
2Triple Negative Breast Neoplasms
01/2018 - 11/2016
2Neoplasm Metastasis (Metastasis)
01/2018 - 11/2016
1Crohn Disease (Crohn's Disease)
11/2021
1Necrosis
12/2020
1Cross Infection (Nosocomial Infection)
05/2013

Drug/Important Bio-Agent (IBA)

7Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 01/2016
5CytokinesIBA
06/2021 - 10/2016
5Peroxidase (Myeloperoxidase)IBA
01/2021 - 10/2016
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018 - 05/2013
3Dextran SulfateIBA
06/2021 - 01/2017
3CateninsIBA
10/2018 - 01/2015
3Cisplatin (Platino)FDA LinkGeneric
10/2018 - 01/2015
3NADPH Oxidases (NAD(P)H oxidase)IBA
10/2018 - 06/2015
3AcidsIBA
08/2018 - 10/2016
3matrigelIBA
01/2018 - 06/2015
3Pharmaceutical PreparationsIBA
10/2017 - 01/2016
2Hormones (Hormone)IBA
01/2021 - 11/2016
22,4,5-trimethylpyridin-3-olIBA
12/2020 - 10/2018
2Biomarkers (Surrogate Marker)IBA
12/2020 - 10/2016
2pyridineIBA
10/2018 - 01/2018
2Sunitinib (Sutent)FDA Link
10/2018 - 10/2017
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 10/2017
2Small Interfering RNA (siRNA)IBA
11/2016 - 06/2015
1TOR Serine-Threonine KinasesIBA
11/2021
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021
1Dextrans (Dextran)FDA Link
01/2021
1SalicylatesIBA
01/2021
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Sodium Salicylate (Salicylate, Sodium)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1alkoxyl radicalIBA
12/2020
1azacyclonolIBA
10/2018
1VitaminsIBA
10/2018
1TI-1-162IBA
05/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2018
1GelatinasesIBA
01/2018
1tdTomatoIBA
01/2018
1indacrinoneIBA
01/2018
1cathepsin SIBA
01/2018
1batimastat (BB 94)IBA
01/2018
1Biological ProductsIBA
01/2018
1EnzymesIBA
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1src-Family KinasesIBA
01/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2018
1Matrix Metalloproteinase InhibitorsIBA
01/2018
1BJ-1301IBA
10/2017
1LigandsIBA
10/2017
1alpha-TocopherolFDA Link
10/2017
1Stem Cell FactorIBA
10/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017
1Tryptophan HydroxylaseIBA
11/2016
1serotonin 7 receptorIBA
11/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2016
1Antineoplastic Agents (Antineoplastics)IBA
01/2016
1BJ-1108IBA
01/2016
1Matrix Metalloproteinases (MMPs)IBA
06/2015
1AMP-Activated Protein KinasesIBA
06/2015
17-O-succinyl macrolactin AIBA
01/2015
1Fluorouracil (Carac)FDA LinkGeneric
01/2015
1macrolactin AIBA
01/2015
1TankyrasesIBA
01/2015
1Virulence Factors (Pathogenicity Factors)IBA
05/2013
1Carotenoids (Carotene)IBA
05/2013
1staphyloxanthinIBA
05/2013

Therapy/Procedure

4Therapeutics
01/2018 - 10/2016
2Oral Administration
08/2018 - 01/2018
1Drug Therapy (Chemotherapy)
11/2016